HHS recently released a final rule that allows practitioners in Opioid Treatment Programs to start patients on methadone or buprenorphine via telehealth. However, the final rule does not apply to the broader range of providers, leading telehealth advocates to call for additional changes from the DEA.

The post Telehealth Advocates: HHS Has Done Its Bit on Expanding OUD Treatment; DEA Needs to Step Up appeared first on MedCity News.

Through a new partnership, Talkspace clinicians can refer patients with opioid use disorder to Bicycle Health for its addiction services, while Bicycle Health can refer its patients to Talkspace to treat co-occurring mental health conditions.

The post Talkspace, Bicycle Health Partner To Support Patients with Opioid Use Disorder appeared first on MedCity News.

Through a new partnership, Bicycle Health providers can prescribe patients buprenorphine extended release injections (otherwise known as Sublocade), which can be administered by a pharmacist at an Albertsons pharmacy.

The post Bicycle Health, Albertsons Form Partnership To Expand Access to OUD Treatment appeared first on MedCity News.

There is inadequate substance use disorder support for people who are incarcerated or are leaving incarceration. But there are opportunities to make improvements, experts say.

The post ‘A Criminal Justice Approach to a Public Health Problem’: How the Justice System Can Improve SUD Support appeared first on MedCity News.

The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.

The post Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances appeared first on MedCity News.

The DEA recently released proposed rules that would require an in-person visit before a patient can receive a telehealth prescription for a controlled substance. The DEA touts the change as a way to ensure patient safety, but several telehealth advocates argue it will greatly disrupt access for those who need the drugs — especially at a time when the mental health and substance use crisis is growing.

The post ‘The Stakes Couldn’t Be Higher’: How DEA’s Proposal Will Affect Telehealth Controlled Substance Prescribing appeared first on MedCity News.

The collaboration, which was announced last week, is between Bicycle Health, Wellpath and the Federal Bureau of Prisons. It will provide virtual opioid use disorder services to those living in the Bureau’s residential reentry centers in 42 states.

The post New Collaboration Brings Opioid Use Disorder Treatment to Formerly Incarcerated Patients appeared first on MedCity News.

The Covid-19 public health emergency waived a rule that required a practitioner to conduct an in-person medical exam before prescribing controlled substances via telemedicine. Once the public health emergency ends on May 11, those with substance use disorder could be greatly affected, experts are warning.

The post Virtual Substance Use Disorder Companies Sound Alarm Over PHE Ending appeared first on MedCity News.

Bicycle Health provides medication for addiction treatment. Through its telehealth platform, it also offers a team of medical experts, a customized treatment plan, same-day prescription refills for medication management, peer support groups and therapy.

The post Evernorth taps Bicycle Health for virtual opioid use disorder treatment appeared first on MedCity News.

Temporary policy changes during the Covid-19 pandemic let people access substance use treatment over telehealth for the first time. Now, healthcare providers and policymakers are watching legislation that would allow patients to continue to access these services virtually.

The post Providers watch legislation that would extend telehealth treatment for substance use appeared first on MedCity News.